Bjorn Staehr Madsen
Overview
Explore the profile of Bjorn Staehr Madsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stankevic E, Israelsen M, Juel H, Madsen A, Angquist L, Aldiss P, et al.
Liver Int
. 2023 Aug;
43(12):2680-2691.
PMID: 37592403
Background: Frequent binge drinking is a known contributor to alcohol-related harm, but its impact on systemic and hepatic inflammation is not fully understood. We hypothesize that changes in immune markers...
2.
Israelsen M, Alvarez-Silva C, Madsen B, Hansen C, Torp N, Johansen S, et al.
Gut
. 2023 Jun;
73(6):1041-1044.
PMID: 37344168
No abstract available.
3.
Israelsen M, Madsen B, Torp N, Johansen S, Hansen C, Detlefsen S, et al.
Lancet Gastroenterol Hepatol
. 2023 Mar;
8(6):523-532.
PMID: 36893774
Background: Alcohol is the leading cause of liver-related mortality worldwide. The gut-liver axis is considered a key driver in alcohol-related liver disease. Rifaximin-α improves gut-barrier function and reduces systemic inflammation...
4.
Hansen C, Gram-Kampmann E, Hansen J, Hugger M, Madsen B, Jensen J, et al.
Ann Intern Med
. 2022 Dec;
176(1):10-21.
PMID: 36508737
Background: It remains unclear if a low-carbohydrate, high-fat (LCHF) diet is a possible treatment strategy for type 2 diabetes mellitus (T2DM), and the effect on nonalcoholic fatty liver disease (NAFLD)...
5.
Thorhauge K, Thiele M, Detlefsen S, Rasmussen D, Johansen S, Madsen B, et al.
Hepatol Commun
. 2022 Oct;
6(12):3421-3432.
PMID: 36264145
Alcohol-associated liver fibrosis accumulates over decades, driven by hepatic inflammation and cell death. We investigated the diagnostic accuracy of keratin-18 degradation, measured using serum M30 and M65 levels, and the...
6.
7.
Israelsen M, Kim M, Suvitaival T, Madsen B, Hansen C, Torp N, et al.
JHEP Rep
. 2021 Aug;
3(5):100325.
PMID: 34401690
Background & Aims: In experimental models, alcohol induces acute changes in lipid metabolism that cause hepatocyte lipoapoptosis and inflammation. Here we study human hepatic lipid turnover during controlled alcohol intoxication....
8.
Israelsen M, Juel H, Detlefsen S, Madsen B, Rasmussen D, Larsen T, et al.
Clin Gastroenterol Hepatol
. 2020 Dec;
20(8):1784-1794.e9.
PMID: 33279778
Background & Aims: Individual risk for developing alcohol-related liver disease (ALD) varies greatly. We hypothesized that metabolic risk factors and genetic polymorphisms predict severity of ALD. Methods: Biopsy-controlled, cross-sectional study...
9.
Elshaarawy O, Mueller J, Guha I, Chalmers J, Harris R, Krag A, et al.
JHEP Rep
. 2020 Feb;
1(2):99-106.
PMID: 32039357
Background & Aims: Both liver stiffness (LS) and spleen stiffness (SS) are widely used to non-invasively assess liver fibrosis and portal hypertension, respectively. We aimed to identify the impact of...
10.
Israelsen M, Dahl E, Madsen B, Wiese S, Bendtsen F, Moller S, et al.
Am J Physiol Gastrointest Liver Physiol
. 2019 Dec;
318(2):G313-G321.
PMID: 31841026
Acute kidney injury and hepatorenal syndrome (HRS) are frequent complications in patients with cirrhosis and ascites. First-line treatment is terlipressin, which reverses HRS in ~40% of patients but also lowers...